MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024

The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI’s successful award of the tender from the Republic of Ireland’s Health Service Executive (HSE) for the installation of our Contour+ auto contouring solution at Cork University Hospital [1].

At MVision AI, we are delighted to partner with the St. Luke Radiation Oncology Network, supporting them in fulfilling their mission of striving for excellence in cancer treatment, patient care, research, and education. We eagerly anticipate witnessing the impact that the implementation of Contour+ will have on the network and the efficiency of day-to-day operations. Furthermore, we are pleased to collaborate with SLORN on the implementation of Guide & Verify, our newly released solutions designed to enhance your staff’s expertise and facilitate volumetric comparisons of contours in the Auto-segmentation space“, says Sara La Sivita, EMEA Sales Director of MVision AI.

SLRON provides the largest radiation oncology service in Ireland across three centers in St. Luke’s Hospital, Rathgar and on the campuses of St. James’s Hospital and Beaumont Hospital. SLRON is dedicated to excellence in patient care, research and education with patients and committed to providing the most modern radiation oncology service possible.

Phil Neale, Xiel Key Account Consultant added: “This partnership with the HSE follows a strong tradition of adoption of new technologies that benefit patients, and we are delighted to be part of that. It is a pleasure seeing that the MVision AI GBS™ solution installed at St Luke’s Radiation Oncology Network is already relieving effing pressures , and we expect the benefits on treatment waiting times to be borne out in the coming months. We thank the team at St Luke’s for their work in getting this technology installed, and are looking forward to a continued partnership that benefits patients for years to come”.

About MVision AI
MVision AI is an innovative software service provider for radiotherapy treatment planning. Our AI-powered automatic segmentation tool, Contour+, helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow.
MVision.ai
MVision AI Linkedin page
MVision AI Facebook page
MVision AI Twitter page

About Xiel.
Xiel is a specialist distributor of medical technologies in the UK and Ireland. We work with global leading solution providers; therefore, continuously improving efficiency and quality for our customers. Our partners research and develop highly specific products for what is often a small world market. The expertise of Xiel lies in our deep understanding of the structure and organization of radiotherapy departments in the UK and Ireland, for us to advise on the best solutions possible. Xiel. Exceptional Products. Extraordinary Service. Everyday.
Xiel.co.uk
Xiel Linkedin page

About St Luke’s Radiation Oncology Network
Since it opened in May 1954, St Luke’s Hospital in Rathgar, Dublin, has been caring for cancer patients from all over Ireland. The St. Luke’s Radiation Oncology Network is dedicated to being a world class leader in cancer treatment, patient care, research and education. In striving for this excellence, the holistic needs of patients and their families are SLRON’s greatest concern.
Stlukesnetwork.ie

[1] MVision.ai – Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

1.5.2024

MVision AI receives TGA approval and market authorization for Australia

HELSINKI, Finland - May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under the “Image Segmentation Application Software” for image analysis algorithms to be used in radiation therapy treatment planning workflows. Contour+ accelerates the contouring process, provides guidance…

Press Releases

29.4.2024

Dharanipathy Rangaraj Appointed as CEO of MVision AI

Helsinki, Uusimaa - April 29, 2024 – MVision AI, a pioneering company in developing innovative AI solutions in the radiation oncology & imaging space, proudly announces the appointment of Dharanipathy Rangaraj as its new Chief Executive Officer (CEO). In his new capacity as CEO of MVision AI, Dharani will spearhead…

Press Releases

14.2.2024

New proofs supporting the efficacy of radiation therapy for kidney cancer 

February is the month when Cancer research UK raises awareness about kidney cancer. In 2020 over 400 000 people were diagnosed with this disease, and almost 180 000 died, worldwide. In the UK, there are over 13 000 new cases each year, on average, and almost 5000 lost lives. The…

Articles